Baidu
map

8月23日全球新冠肺炎(COVID-19)疫情简报,确诊超2335万,死亡超80万,中国疫苗研发进展迅速

2020-08-23 MedSci原创 MedSci原创

Worldometers世界实时统计数据显示,截至北京时间8月23日8时11分,全球新冠肺炎(COVID-19)累计确诊病例突破2335万例,达到23,359,254例,累计死亡病例超过80.7万例,

Worldometers世界实时统计数据显示,截至北京时间8月23日8时11分,全球新冠肺炎COVID-19)累计确诊病例突破2335万例,达到23,359,254例,累计死亡病例超过80.7万例,达到807,690例,康复15,889,752例。美国新冠肺炎累计确诊病例全球最多,突破584万例,达到5,840,433例,累计死亡病例超过18万例,达到180,153例。昨日报道:8月22日全球新冠肺炎(COVID-19)疫情简报,确诊超2308万,谨防11月份第二波疫情

据美国约翰斯·霍普金斯大学发布的全球新冠肺炎数据实时统计系统,截至美国东部时间8月22日晚6时,全美共报告新冠肺炎确诊5660719例,死亡176243例。过去24小时,美国新增确诊44721例,新增死亡1039例。

世卫组织网站数据显示,截至欧洲中部时间22日14时09分(北京时间20时09分),全球确诊病例较前一日增加275499例,达到22812491例;死亡病例增加5926例,达到795132例。

7月22日中国正式启动新冠疫苗紧急使用

国家卫生健康委科技发展中心主任、国务院联防联控机制科研攻关组疫苗研发专班工作组组长郑忠伟在节目中表示,我国已于7月22日正式启动新冠疫苗的紧急使用。

《疫苗管理法》明确规定,当出现特别重大公共卫生事件,由国家卫生健康委提出紧急使用疫苗的申请,由国家药监局组织专家论证并同意,由国家卫生健康委在一定范围、一定时限内紧急使用疫苗。目的是在医务人员、防疫人员、边检人员以及保障城市基本运行人员等特殊人群中,先建立起免疫屏障,整个城市的运行就会有稳定的保障。

新冠疫苗Ⅲ期临床试验入组超2万人,创造多个全球第一,安全性非常好

Ⅲ期临床研究,是关乎疫苗能否上市进行大规模人群接种的重要一步。国药集团中国生物董事长、国家“863”计划疫苗项目首席科学家杨晓明表示,6月23日,中国生物新冠灭活疫苗国际临床(Ⅲ期)阿拉伯联合酋长国启动仪式在中国北京、武汉、阿联酋阿布扎比三地,以视频会议方式同步举行。截至目前,入组接种人数已超过2万人,并创造了多个全球第一;安全性非常好,有效性正在进一步观察中;入组速度好于预期,非常值得期待。

8月20日、8月21日,国药集团中国生物分别与秘鲁、摩洛哥以及阿根廷签订有关新冠灭活疫苗Ⅲ期临床试验的合作协议并举行启动仪式。这标志着中国生物新冠灭活疫苗Ⅲ期临床试验全面提速。更多的样本量及不同地区的临床试验数据将大大提升新冠灭活疫苗上市进程,为人类命运共同体、全球人民的健康福祉,贡献中国智慧与力量。

一支小小的新冠疫苗,凝集了无数中国科研人员的心血、智慧和汗水。对所有人来说,它意味着生命、健康、希望、未来。在打造疫苗这一全球公共卫生产品的道路上,中国疫苗先锋队带着责任、带着使命,正在全速前进。

来源:微信公号“中国生物”,中新网,人民日报

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-24 heli0118
  3. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-24 rayms

    很详细,很有用,坐等明日更新。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 ms7000000689223974

    讲的很详细,很有用,赞一个

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 wxl882001

    了解

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 ms6000001655887159

    保护好自己

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 仁心济世

    7月22日中国正式启动新冠疫苗紧急使用#新冠病毒疫苗#你怎么看?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 ms7000000689223974

    很有用,很不错,谢谢分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 ms7000000689223974

    信息披露的非常准确,很及时

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1634333, encodeId=4d041634333e7, content=<a href='/topic/show?id=2346e05209f' target=_blank style='color:#2F92EE;'>#疫苗研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70520, encryptionId=2346e05209f, topicName=疫苗研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9922152235, createdName=lilili1111, createdTime=Tue Dec 29 05:25:11 CST 2020, time=2020-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300415, encodeId=e157130041544, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Mon Aug 24 23:25:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812777, encodeId=ccec812e7774, content=很详细,很有用,坐等明日更新。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Mon Aug 24 18:05:11 CST 2020, time=2020-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812506, encodeId=2c52812506c3, content=讲的很详细,很有用,赞一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=158, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 20:05:22 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812461, encodeId=1cf5812461d8, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Sun Aug 23 19:03:56 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812430, encodeId=4a3681243044, content=保护好自己, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d95410991, createdName=ms6000001655887159, createdTime=Sun Aug 23 15:36:29 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812424, encodeId=c68a81242461, content=7月22日中国正式启动新冠疫苗紧急使用<a href='/topic/show?id=6b54580e217' target=_blank style='color:#2F92EE;'>#新冠病毒疫苗#</a>你怎么看?, beContent=null, objectType=article, channel=null, level=null, likeNumber=245, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58072, encryptionId=6b54580e217, topicName=新冠病毒疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Aug 23 14:41:03 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812376, encodeId=be628123e6c1, content=很有用,很不错,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 13:01:55 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812296, encodeId=73c6812296fe, content=信息披露的非常准确,很及时, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Sun Aug 23 12:41:23 CST 2020, time=2020-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812257, encodeId=68fa81225e0e, content=仍需继续努力, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/04/21/e52f233b719cbd2825d73db8431d285e.jpg, createdBy=7b6c2294328, createdName=策瑜爱发呆, createdTime=Sun Aug 23 11:31:14 CST 2020, time=2020-08-23, status=1, ipAttribution=)]
    2020-08-23 策瑜爱发呆

    仍需继续努力

    0

相关资讯

Lancet:新冠肺炎病毒Δ382缺失突变后毒性降低

SARS-CoV-2病毒Δ382突变株造成的感染症状较轻,病毒基因组开放阅读框8突变后病毒毒性的降低对治疗和疫苗的研发有一定的指导作用

同样嗅觉失灵 新冠感染与普通感冒大有不同

新冠病毒感染者常出现嗅觉失灵。欧洲研究人员最新发现,这种嗅觉失灵和普通感冒引起的嗅觉失灵存在很大差别,相关发现可能有助找到更快捷的新冠感染筛查方法。

8月19日全球新冠肺炎(COVID-19)疫情简报,确诊超2227万例,中美疫苗标准很低有效率为50%,疫情形势正在好转

据Worldometers实时统计数据显示,截至北京时间8月19日07时32分,全球新冠肺炎(COVID-19)确诊病例达2227万例,新增234,048例至22,277,556例,死亡病例达78万例

8月20日全球新冠肺炎(COVID-19)疫情简报,确诊超2255万,新冠可能带来一轮婴儿潮

Worldometer网站实时统计数据显示,截至北京时间8月20日7时30分左右,全球累计确诊新冠肺炎(COVID-19)病例22,553,379例,累计死亡病例789,863例,康复15,282,4

8月21日全球新冠肺炎(COVID-19)疫情简报,确诊超2281万,全球1亿人口陷入极端贫困

据Worldometers实时统计数据显示,截至北京时间8月21日07时11分,全球新冠肺炎(COVID-19)确诊病例达2281万例,新增242,687例至22,812,285例,死亡病例达79万例

8月22日全球新冠肺炎(COVID-19)疫情简报,确诊超2308万,谨防11月份第二波疫情

据Worldometers实时统计数据显示,截至北京时间8月22日07时34分,全球新冠肺炎(COVID-19)确诊病例达2308万例,新增236927例至23087090例,死亡病例达80万例,新增

Baidu
map
Baidu
map
Baidu
map